Brian holds a Ph.D. in Biomedical Engineering from Case Western Reserve University and a Bachelors of Science in Biomedical Engineering from Georgia Institute of Technology. He has co-authored numerous scientific articles based on his previous research in the field of brain-computer interfaces and functional electrical stimulation. He is also passionate about making scientific advances easily accessible to the public.
BH4 (tetrahydrobiopterin) plays an important role in the activity of the enzyme that is dysfunctional, or not working properly, in people with phenylketonuria (PKU). Here is more information about BH4 ... Read more
An electroencephalogram, commonly known as an EEG, is a diagnostic test for assessing brain waves that doctors may use in treating patients with phenylketonuria (PKU). The technique primarily is used ... Read more
BioMarin has set up a registry to monitor phenylketonuria (PKU) patients who have received its treatment Kuvan (sapropterin dihydrochloride). The information collected in the database — called the phenylketonuria demographics, ... Read more
Phenylketonuria (PKU) cases have been reported to different degrees in countries across the world. There have been a number of studies to estimate its prevalence, or how common the disease ... Read more
Phenylketonuria (PKU) is a rare genetic disorder that can lead to a host of neurological and developmental problems. Since PKU is rare, gathering as much information as possible about the ... Read more
Palynziq (pegvaliase-pqpz) is a medication by BioMarin for the treatment of phenylketonuria (PKU) in adults who have phenylalanine (Phe) blood levels above 600 micromoles/L with their current treatments. How does ... Read more